Advertisement · 728 × 90
#
Hashtag
#clinical_trials
Advertisement · 728 × 90
Preview
Lunai Bioworks and Geneial Collaborate to Enhance Rare Disease Research and Patient Data Integration Lunai Bioworks and Geneial have signed a Letter of Intent to develop patient cohorts to advance drug discovery for rare neurological disorders, streamlining data into actionable insights.

Lunai Bioworks and Geneial Collaborate to Enhance Rare Disease Research and Patient Data Integration #United_States #Clinical_Trials #Sacramento #Lunai_Bioworks #Geneial_Inc

0 0 0 0
Preview
Caris Life Sciences Launches Innovative Clinical Trial Solution to Increase Access for Underserved Cancer Patients Caris Life Sciences unveils a groundbreaking solution to enhance access to precision oncology trials, targeting historically underserved cancer patients at community oncology sites.

Caris Life Sciences Launches Innovative Clinical Trial Solution to Increase Access for Underserved Cancer Patients #USA #Caris_Life_Sciences #Irving #Clinical_Trials #Precision_Oncology

0 0 0 0
Preview
Caliway's Innovative Fat Reduction Drug CBL-514 Gains Strong Recognition in Phase 2 Clinical Trials Caliway Biopharmaceuticals' CBL-514 for fat reduction has received significant academic acknowledgment following successful Phase 2 clinical trials, highlighting its potential.

Caliway's Innovative Fat Reduction Drug CBL-514 Gains Strong Recognition in Phase 2 Clinical Trials #Taiwan #New_Taipei_City #Clinical_Trials #Caliway_Biopharmaceuticals #CBL-514

0 0 0 0
Preview
Understanding the Complexities of Muscle Composition in Weight Loss: Insights from an Upcoming Webinar Join an insightful webinar that delves into the often-overlooked aspects of muscle composition during weight loss, crucial for clinical trials. Learn from expert speakers about assessment techniques and their implications.

Understanding the Complexities of Muscle Composition in Weight Loss: Insights from an Upcoming Webinar #None #Clinical_Trials #weight_loss #muscle_composition

0 0 0 0
Preview
Transforming Clinical Trials with Risk-Based QA Oversight: An Insightful Webinar Join our upcoming webinar to learn how to enhance quality assurance in clinical trials using risk-based methodologies in compliance with ICH E6 (R3).

Transforming Clinical Trials with Risk-Based QA Oversight: An Insightful Webinar #Canada #Toronto #Clinical_Trials #ICH_E6 #Xtalks

0 0 0 0
Preview
Exploring Community-Based Research Models to Enhance Clinical Trial Readiness Join the free webinar on community-rooted research models that lower patient burden, enhance access, and improve retention among diverse populations.

Exploring Community-Based Research Models to Enhance Clinical Trial Readiness #Canada #Toronto #Clinical_Trials #Community_Engagement #Xtalks

1 0 0 0
Preview
ProofPilot Invites Pharma and Biotech Leaders to CORE Symposium for Clinical Trials Insights Join industry leaders at the 2nd CORE Symposium hosted by ProofPilot on April 15, 2026, at Boston's Fenway Park, focusing on clinical trial challenges.

ProofPilot Invites Pharma and Biotech Leaders to CORE Symposium for Clinical Trials Insights #United_States #Boston #Clinical_Trials #ProofPilot #CORE_Symposium

0 0 0 0
Preview
Groundbreaking Research Validates Paradigm Health's EHR-Integrated Trial Solutions for Oncology Recent peer-reviewed studies confirm the effectiveness of Paradigm Health's EHR-integrated eSource platform, enhancing data collection in oncology trials.

Groundbreaking Research Validates Paradigm Health's EHR-Integrated Trial Solutions for Oncology #United_States #Columbus #Clinical_Trials #Paradigm_Health #EHR-integrated

0 0 0 0
Preview
The Projected Growth of Digital Biomarkers Market to $17.73 Billion by 2031 The digital biomarkers market is anticipated to soar from $7.41 billion in 2026 to $17.73 billion by 2031, marking a substantial growth rate driven by clinical trials and technological adoption.

The Projected Growth of Digital Biomarkers Market to $17.73 Billion by 2031 #United_States #Delray_Beach #Clinical_Trials #wearable_technology #Digital_Biomarkers

0 0 0 0
Preview
Hoth Therapeutics Closes $2 Million Offering to Fuel Innovative Therapies Hoth Therapeutics has successfully closed a registered direct offering worth $2 million, aimed at advancing its clinical-stage innovations in biopharmaceuticals.

Hoth Therapeutics Closes $2 Million Offering to Fuel Innovative Therapies #USA #New_York #Clinical_Trials #biotechnology #Hoth_Therapeutics

0 0 0 0
Preview
Signant Health Expands Expertise with Dr. Graham C. Ellis as Clinical VP Signant Health is enhancing its capabilities in metabolic disease and diabetes research with the appointment of Dr. Graham C. Ellis as Clinical VP.

Signant Health Expands Expertise with Dr. Graham C. Ellis as Clinical VP #USA #Philadelphia #Clinical_Trials #Signant_Health #Dr._Graham_C._Ellis

0 0 0 0
Preview
Panoramic Health and West Coast Kidney Institute Open New Research Center for Cardio-Renal-Metabolic Clinical Trials The Concord Cardio-Renal Research Institute is established by Panoramic Health and West Coast Kidney Institute to enhance clinical trial accessibility.

Panoramic Health and West Coast Kidney Institute Open New Research Center for Cardio-Renal-Metabolic Clinical Trials #United_States #Clinical_Trials #Concord #Panoramic_Health #Concord_Institute

0 0 0 0
Preview
Hoth Therapeutics' HT-001 Scores Approval in Hungary After Successful Clinical Trial Phase Hoth Therapeutics' HT-001 demonstrates promising clinical results, achieving key endpoints and gaining regulatory approval for trial expansion in Hungary, paving the way for broader patient enrollment.

Hoth Therapeutics' HT-001 Scores Approval in Hungary After Successful Clinical Trial Phase #None #Clinical_Trials #Hoth_Therapeutics #HT-001

0 0 0 0
Preview
LabConnect Introduces SampleGISTICS® 2.0 to Transform Clinical Sample Capture Process LabConnect has unveiled SampleGISTICS® 2.0, a groundbreaking mobile application that streamlines clinical trial sample management and improves data visibility.

LabConnect Introduces SampleGISTICS® 2.0 to Transform Clinical Sample Capture Process #USA #Raleigh #LabConnect #Clinical_Trials #SampleGISTICS

0 0 0 0
Preview
LabConnect Launches SampleGISTICS® 2.0: Revolutionizing Clinical Sample Collection LabConnect introduces SampleGISTICS® 2.0, a ground-breaking application designed to enhance the efficiency of clinical sample collection and tracking.

LabConnect Launches SampleGISTICS® 2.0: Revolutionizing Clinical Sample Collection #USA #Raleigh #LabConnect #Clinical_Trials #SampleGISTICS

0 0 0 0
Preview
LabConnect Unveils SampleGISTICS® 2.0 to Modernize Clinical Sample Workflow LabConnect introduces SampleGISTICS® 2.0, an innovative mobile app aimed at improving clinical trial sample management through real-time digital solutions.

LabConnect Unveils SampleGISTICS® 2.0 to Modernize Clinical Sample Workflow #USA #Raleigh #LabConnect #Clinical_Trials #SampleGISTICS

0 0 0 0
Preview
How LabConnect's SampleGISTICS® 2.0 Revolutionizes Clinical Trial Sample Management LabConnect introduces SampleGISTICS® 2.0, a mobile app that transforms sample management in clinical trials, enhancing efficiency and accuracy.

How LabConnect's SampleGISTICS® 2.0 Revolutionizes Clinical Trial Sample Management #USA #Raleigh #LabConnect #Clinical_Trials #SampleGISTICS

0 0 0 0
Preview
LabConnect Unveils SampleGISTICS 2.0: Revolutionizing Clinical Trial Sample Management LabConnect has launched SampleGISTICS 2.0, a revolutionary mobile application for real-time sample management in clinical trials. This app aims to digitize processes and improve efficiency.

LabConnect Unveils SampleGISTICS 2.0: Revolutionizing Clinical Trial Sample Management #USA #Raleigh #LabConnect #Clinical_Trials #SampleGISTICS

0 0 0 0
Preview
Tigermed Reports Impressive Growth in 2025 Annual Results with Record Revenue Hangzhou Tigermed Consulting Co. Ltd. announces substantial revenue growth for 2025, signaling a strong future for its global biopharmaceutical services.

Tigermed Reports Impressive Growth in 2025 Annual Results with Record Revenue #China #biopharmaceuticals #Hangzhou #Clinical_Trials #Tigermed

0 0 0 0
Preview
Keymed Biosciences Reports Impressive Annual Results for 2025 with Growth in Revenue and Product Launches Keymed Biosciences achieved remarkable financial results in 2025, marking a significant increase in revenue alongside successful product launches and clinical advances.

Keymed Biosciences Reports Impressive Annual Results for 2025 with Growth in Revenue and Product Launches #China #Beijing #Clinical_Trials #Keymed_Biosciences #Kangyueda

1 0 0 0
Preview
Innovation in EEG Research: Zeto's 2026 Clinical Trial Sponsorship Winners Announced Zeto, Inc. reveals the winners of its 2026 Clinical Trial Sponsorship Program focused on EEG advancements in stroke, delirium, and epilepsy care.

Innovation in EEG Research: Zeto's 2026 Clinical Trial Sponsorship Winners Announced #United_States #Raleigh #Clinical_Trials #Zeto #EEG

0 0 0 0
Preview
AccessHope Achieves Major Milestone with Over 10 Million Members in Expert Cancer Care Access AccessHope has grown significantly, reaching over 10 million members and enhancing access to expert cancer care through innovative services.

AccessHope Achieves Major Milestone with Over 10 Million Members in Expert Cancer Care Access #USA #Clinical_Trials #Cancer_Care #Duarte #AccessHope

0 0 0 0
Preview
DermTech 2.0 Announces Expanded Clinical Trial Support Services for DermTech Stratum DermTech 2.0 has launched expanded clinical trial support services under DermTech Stratum, enhancing its precision dermatology offerings.

DermTech 2.0 Announces Expanded Clinical Trial Support Services for DermTech Stratum #United_States #San_Diego #Clinical_Trials #DermTech #Smart_Sticker

0 0 0 0
Preview
PhaseV Introduces Integrated AI Solutions to Revolutionize Clinical Trials in 2026 PhaseV is set to showcase its innovative AI/ML solutions at key conferences in 2026, aiming to enhance clinical trial efficiency and patient outcomes.

PhaseV Introduces Integrated AI Solutions to Revolutionize Clinical Trials in 2026 #United_States #Boston #Clinical_Trials #PhaseV #AI/ML

1 0 0 0
Preview
Pinnacle Medicines Secures $89 Million to Propel Oral Peptide Therapy Forward Into Clinical Trials Pinnacle Medicines has successfully closed an oversubscribed Series B financing of $89 million to advance its oral peptide therapeutic pipeline into clinical trials focusing on immunology and cardiometabolic diseases.

Pinnacle Medicines Secures $89 Million to Propel Oral Peptide Therapy Forward Into Clinical Trials #United_States #Clinical_Trials #Doylestown #Pinnacle_Medicines #Oral_Peptide

0 0 0 0
Preview
Building a Drug Discovery Ecosystem: Seminar on Clinical Trials and Regulations in Japan Join us for a pivotal seminar on Japan's drug discovery ecosystem featuring insights from the Ministry of Health, Labour and Welfare. Explore innovative strategies and clinical trial advancements.

Building a Drug Discovery Ecosystem: Seminar on Clinical Trials and Regulations in Japan #Japan #Tokyo #Clinical_Trials #Drug_Discovery #JPI_Seminar

0 0 0 0
Preview
Atossa Therapeutics Unveils Financial Progress and Strategic Insights for 2025 Atossa Therapeutics provides an overview of its financial results for 2025, focuses on innovative oncology therapies and strategic advancements.

Atossa Therapeutics Unveils Financial Progress and Strategic Insights for 2025 #United_States #Seattle #Clinical_Trials #Atossa_Therapeutics #Z-Endoxifen

0 0 0 0
Preview
Armata Pharmaceuticals Reports Financial Outcomes for 2025 and Future Plans Armata Pharmaceuticals has announced its financial results for Q4 and the full year of 2025, highlighting significant challenges and future strategies.

Armata Pharmaceuticals Reports Financial Outcomes for 2025 and Future Plans #USA #Los_Angeles #Clinical_Trials #Armata_Pharmaceuticals #bacteriophage_therapies

0 0 0 0
Preview
Exploring the Impact of Advanced RBQM Strategies in Clinical Trials via an Upcoming Webinar Join Xtalks' upcoming webinar to understand how effective risk-based quality management can enhance clinical trial outcomes and streamline processes.

Exploring the Impact of Advanced RBQM Strategies in Clinical Trials via an Upcoming Webinar #Canada #Toronto #Clinical_Trials #Xtalks #RBQM

0 0 0 0
Preview
Clover Biopharmaceuticals Announces Promising Phase I Clinical Trial Results for RSV Vaccine Re-Vaccination in Older Adults Clover Biopharmaceuticals reveals new data from its Phase I trial showing a significant increase in RSV antibodies, boosting hopes for better elderly protection.

Clover Biopharmaceuticals Announces Promising Phase I Clinical Trial Results for RSV Vaccine Re-Vaccination in Older Adults #China #Shanghai #Clinical_Trials #RSV_Vaccine #Clover_Biopharmaceuticals

1 0 0 0